Searchable abstracts of presentations at key conferences in endocrinology

ea0072oc3 | Oral Communications | UKINETS2020

OMIC gene cluster evaluation amplifies the prognostic accuracy of the NETest

Kidd Mark , Kitz Alexandra , Drozdov Ignat , Modlin Irvin

Background: The NETest is a multi-gene assay comprising 51 circulating neuroendocrine tumor specific transcripts. The quotient of the 51-gene assay is based upon multi-algorithmic data analysis. Eight cancer hallmarks or ‘omes’ (apoptome, epigenome, growth factor signalome, metabolome, proliferome, plurome, secretome SSTRome) represent 29 genes. The NETest is an accurate diagnostic (>90%) but its prognostic utility has not been assessed. In this study, we describe ex...

ea0073aep372 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Atypical presentation of Type 1 diabetes mellitus

Niven Mark , Kafri Esther , Nissim Elizabeth , Dubin Ina

IntroductionDiabetic ketoacidosis (DKA) is associated with Type 1 diabetes mellitus (T1DM), whilst hyperglycemic hyperosmolar state (HHS) with Type 2 (T2DM). HHS has been well described as a presentation of T1DM in children, but not in adults. We present present a case of T1DM presenting in a young adult as HHS, with severe hyperglycemia but without acidosis.Case reportA 21 year old male presented with a 4 5 ...

ea0094p59 | Metabolism, Obesity and Diabetes | SFEBES2023

Activation of AMPK & p38MAPK Pathways with a Novel Agonistic Compound in LHCN-M2 Skeletal Muscle Myotubes

Brett Ryan , Beall Craig , Hodson Leanne , Renshaw Derek , Turner Mark

Introduction: Pharmacological targeting of skeletal muscle to enhance metabolism through signalling pathways independent of insulin could be effective in treating metabolic diseases such as obesity and type 2 diabetes. BI-9774 is an allosteric agonist which has been shown to have high potency in enhancing 5’ AMP-activated protein kinase (AMPK) activity. The purpose of these experiments was to establish the effects of BI-9774 on AMPK signalling and mitocho...

ea0094p214 | Metabolism, Obesity and Diabetes | SFEBES2023

The effects of physiological and pathophysiological concentrations of fatty acids on lipid droplet accumulation and metabolic function of LHCN-M2 human skeletal muscle cells

Turner Mark , Brett Ryan , Andreou Persefoni , Hodson Leanne , Renshaw Derek

Introduction: Skeletal muscle (SkM) is a major site of carbohydrate and fatty acid (FA) utilisation, where efficient selection between these two substrates is paramount in maintaining metabolic homeostasis. The accumulation of FA in SkM has been suggested to contribute to metabolic diseases such as obesity and type 2 diabetes mellitus. Consequently, there is significant interest in SkM FA metabolism and importantly, how FAs contribute to the metabolic function...

ea0034p367 | Steroids | SFEBES2014

The endocrine response to severe trauma: the Steroids and Immunity from injury to Rehabilitation (SIR) study

Foster Mark , Taylor Angela , Hill Neil , Staruch Rob , O'Neil Donna , Bion Julian , Young Stephen , Midwinter Mark , Lord Janet , Arlt Wiebka

There are 1.21 million deaths from road traffic accidents worldwide. In Afghanistan, there have been 2005 battle injuries over 10 years. Advances in military trauma care have improved survival, resulting in more severely injured individuals entering the trauma care pathway. Improved understanding of endocrine-immune changes after severe trauma may facilitate novel interventions to improve outcomes. We prospectively recruited 102 severely injured patients at the Queen Elizabeth...

ea0034p368 | Steroids | SFEBES2014

Glucocorticoid activation in muscle by 11β-hydroxysteroid dehydrogenase type 1: contributions to inflammatory muscle wasting

Hardy Rowan , Lavery Gareth , Pierson Mark , Doug Craig , Filer Andrew , Buckley Christopher , Lord Janet , Stewart Paul , Cooper Mark , Raza Karim

Muscle wasting remains a significant complication in patients with inflammatory disease where it contributes to disability, risk of falls and early mortality. Interestingly, muscle wasting in patients with glucocorticoid excess mirrors that observed in patients with inflammatory disease. We have previously reported that the glucocorticoid activating enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is potently up-regulated within mesenchymal derived cell popu...

ea0028p248 | Pituitary | SFEBES2012

‘Isolated acquired secondary hypogonadism’ in men referred to an adult endocrine clinic

Kandasamy Narayanan , Baxter Mark , Skittrall Jordan , Annamalai Anand Kumar , Antoun Nagui , Simpson Helen , Halsall David , Gurnell Mark

Background: Acquired male secondary hypogonadism is a relatively common cause of referral to the endocrine clinic. However, the extent to which further investigation is required, and the indications for a trial of testosterone therapy, remain unclear. Aim To review the clinical/biochemical/radiological findings in men presenting with this condition.Methods: We performed a retrospective case analysis of 41 consecutive patients referred to our clinic over ...

ea0025p192 | Endocrine tumours and neoplasia | SFEBES2011

Familial adrenocortical carcinoma associated with HNPCC

Kandasamy Narayanan , Nik-Zainal Serena , Annamalai Anand Kumar , Walker Lisa , Happerfield Lisa C , Arends Mark J , Patterson Joan , Gurnell Mark

We report the first case of familial adrenocortical carcinoma (ACC) in association with hereditary non-polyposis colorectal cancer (HNPCC) in a family with a MSH2 germline mutation.HNPCC, an autosomal dominant disorder caused by mutations in one of the DNA mismatch repair (MMR) genes, is the commonest cause of hereditary colon carcinoma, and is associated with an increased risk of certain non-colonic cancers (e.g. endometrial, ovarian, urin...

ea0037gp.04.02 | Steroids | ECE2015

The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure

Sherlock Mark , Behan Lucy Ann , Hannon Mark , Alonso Aurora Aragon , Thompson Christopher , Murray Robert , Crabtree Nicola , Hughes Beverly , Arlt Wiebke , Agha Amar , Toogood Andrew , Stewart Paul M

Context: Patients with hypopituitarism have increased morbidity and mortality. There is ongoing debate around the optimum glucocorticoid replacement therapy.Objective: To assess the effect of glucocorticoid replacement in hypopituitarism on corticosteroid metabolism and its impact on body composition.Design and patients: We assessed the urinary corticosteroid metabolite profile (using gas chromatography/mass spectrometry) and body ...

ea0037ep744 | Pituitary: clinical | ECE2015

Symptoms of gonadal dysfunction are more predictive of hypopituitarism than non-specific symptoms in screening for pituitary dysfunction following moderate or severe traumatic brain injury

Hernandez Martin Cuesta , Hannon Mark J , Crowley Rachel K , Behan Lucy Ann , Tormey William , Rawluk Daniel , Delargy Mark , Agha Amar , Thompson Christopher J

Context: The economic and logistic burden of screening for hypopituitarism following moderate/severe traumatic brain injury (TBI) is considerable. Published guidelines suggest prioritisation for screening of patients with symptoms of pituitary dysfunction.Objective: To evaluate the implementation of targeted symptom-based screening for hypopituitarism after moderate/severe TBI, compared with routine consecutive screening.Design: Gr...